Evidence map›Paper›PMID 29980812›Full record

ArticleCurrent microbiology2018

Evaluation of Legiolert for Quantification of Legionella pneumophila from Non-potable Water.

Melanie M Rech, Brian M Swalla, Jason K Dobranic

Open access · hybridAbstract readEvaluation Study
In one paragraph

Article in Current microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Comparison ofACS ES&T water · 2023
    Article
  7. Article
  8. Article
  9. Review
  10. Performance of Legiolert Test vs. ISO 11731 to ConfirmPathogens (Basel, Switzerland) · 2020
    Article
  11. Pathogens (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Melanie M RechEMSL Analytical, Inc., 1010 Yuma Street, Denver, CO, 80204, USA. mrech@emsl.com.
Brian M SwallaIDEXX Laboratories, Inc., 1 Idexx Dr., Westbrook, ME, 04092, USA.
Jason K DobranicEMSL Analytical, Inc., 5950 Fairbanks North Houston Rd, Houston, TX, 77040, USA.
ASL Analytical (United States) · USIDEXX Laboratories (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Legiolert® is a new culture method for quantification of Legionella pneumophila, which is the primary species associated with Legionnaires' disease. The test is based on a most probable number approach, and differs significantly from traditional culture methods by providing results at 7 days, rapid sample preparation and analysis, and objective interpretation of test results. In this study, we compared the performance of Legiolert with the U.S. Centers for Disease Control and Prevention (CDC) method for detection of L. pneumophila from non-potable samples, primarily comprising cooling tower waters. Our results demonstrated no significant difference between Legiolert and the CDC method for quantification of L. pneumophila. However, Legiolert showed a significant increase in sensitivity when water samples containing higher L. pneumophila concentrations were examined. Cooling tower waters often contain non-Legionella organisms (NLO) that interfere with traditional Legionella test methods, and we observed varying degrees of NLO interference on many CDC method plates. In contrast, Legiolert was resistant to NLO interference and produced a very low rate of false-positive results. Collectively, Legiolert is a sensitive and specific method for quantification of L. pneumophila from non-potable water that provides advantages over the CDC method.

Indexed as

Bacteriological TechniquesCenters for Disease Control and Prevention, U.S.Fresh WaterHumansLegionella pneumophilaLegionnaires' DiseaseSensitivity and SpecificityUnited StatesWater Supply

Identifiers

PMID29980812
PMCPMC6132855
OpenAlexW2812598441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.